The localization of proteins encoded by CRYM, KIAA1199, UBA52, COL9A3, and COL9A1, genes highly expressed in the cochlea
- PMID: 18448257
- DOI: 10.1016/j.neuroscience.2008.03.018
The localization of proteins encoded by CRYM, KIAA1199, UBA52, COL9A3, and COL9A1, genes highly expressed in the cochlea
Abstract
Genes that are highly expressed in the inner ear, as revealed by cDNA microarray analysis, may have a crucial functional role there. Those that are expressed specifically in auditory tissues are likely to be good candidates to screen for genetic alterations in patients with deafness, and several genes have been successfully identified as responsible for hereditary hearing loss. To understand the detailed mechanisms of the hearing loss caused by the mutations in these genes, the present study examined the immunocytochemical localization of the proteins encoded by Crym, KIAA1199 homolog, Uba52, Col9a3, and Col9a1 in the cochlea of rats and mice. Confocal microscopic immunocytochemistry was performed on cryostat sections. Ultrastructurally, postembedding immunogold cytochemistry was applied using Lowicryl sections. Crym protein was predominantly distributed in the fibrocytes in the spiral ligament, as well as the stria vascularis in rats. KIAA1199 protein homolog was localized in various supporting cells, including inner phalangeal, border, inner and outer pillar, and Deiters' cells. Uba52 protein was restrictedly localized within the surface of the marginal cells of the stria vascularis. Collagen type IX was found within the tectorial membrane as well as fibrocytes in the spiral ligament. The present results showed cell-specific localization of the encoded proteins of these highly expressed genes, indicating that the coordinated actions of various molecules distributed in different parts of the cochlea are essential for maintenance of auditory processing in the cochlea.
Similar articles
-
Identification of CRYM as a candidate responsible for nonsyndromic deafness, through cDNA microarray analysis of human cochlear and vestibular tissues.Am J Hum Genet. 2003 Jan;72(1):73-82. doi: 10.1086/345398. Epub 2002 Dec 6. Am J Hum Genet. 2003. PMID: 12471561 Free PMC article.
-
Mutations in the gene encoding KIAA1199 protein, an inner-ear protein expressed in Deiters' cells and the fibrocytes, as the cause of nonsyndromic hearing loss.J Hum Genet. 2003;48(11):564-70. doi: 10.1007/s10038-003-0079-2. Epub 2003 Oct 24. J Hum Genet. 2003. PMID: 14577002
-
Type IX collagen is crucial for normal hearing.Neuroscience. 2005;132(2):493-500. doi: 10.1016/j.neuroscience.2005.01.013. Neuroscience. 2005. PMID: 15802199
-
Potassium ion recycling pathway via gap junction systems in the mammalian cochlea and its interruption in hereditary nonsyndromic deafness.Med Electron Microsc. 2000;33(2):51-6. doi: 10.1007/s007950070001. Med Electron Microsc. 2000. PMID: 11810458 Review.
-
Gene expression profiles of the cochlea and vestibular endorgans: localization and function of genes causing deafness.Ann Otol Rhinol Laryngol. 2015 May;124 Suppl 1:6S-48S. doi: 10.1177/0003489415575549. Epub 2015 Mar 26. Ann Otol Rhinol Laryngol. 2015. PMID: 25814645 Review.
Cited by
-
Genetic Deficiencies of Hyaluronan Degradation.Cells. 2024 Jul 16;13(14):1203. doi: 10.3390/cells13141203. Cells. 2024. PMID: 39056785 Free PMC article. Review.
-
Identification of a novel mutation in CRYM in a Chinese family with hearing loss using whole-exome sequencing.Exp Ther Med. 2020 Aug;20(2):1447-1454. doi: 10.3892/etm.2020.8890. Epub 2020 Jun 12. Exp Ther Med. 2020. PMID: 32742378 Free PMC article.
-
Research on the biological mechanism and potential application of CEMIP.Front Immunol. 2023 Aug 18;14:1222425. doi: 10.3389/fimmu.2023.1222425. eCollection 2023. Front Immunol. 2023. PMID: 37662915 Free PMC article. Review.
-
CEMIP (KIAA1199) induces a fibrosis-like process in osteoarthritic chondrocytes.Cell Death Dis. 2019 Feb 4;10(2):103. doi: 10.1038/s41419-019-1377-8. Cell Death Dis. 2019. PMID: 30718510 Free PMC article.
-
Central Role of CEMIP in Tumorigenesis and Its Potential as Therapeutic Target.J Cancer. 2017 Jul 20;8(12):2238-2246. doi: 10.7150/jca.19295. eCollection 2017. J Cancer. 2017. PMID: 28819426 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases